Antitrust Antitrust

Suit accusing Quest Diagnostics of monopolizing allergy testing, treatment services revived by Fifth Circuit

By Max Fillion
  • 18 May 2021 17:55
  • 18 May 2021 17:55
A suit accusing Quest Diagnostics of monopolizing the market for allergy testing and treatment services in Texas was revived by the US Court of Appeals for the Fifth Circuit today.
A three-judge panel for the Fifth Circuit found that a lower court had erred in finding that the suit wasn’t

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News